Atria Wealth Solutions, Inc. Vertex Pharmaceuticals Inc Transaction History

Atria Wealth Solutions, Inc.

$8.89 Billion
Q3 2024

A detailed history of Atria Wealth Solutions, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 9,735 shares of VRTX stock, worth $4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

9,735

Previous 10,722 9.21%

Holding current value

$4 Million

Previous $5.03 Million 9.91%

% of portfolio

0.05%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$460.0 - $505.78 $454,020 - $499,204	-987 Reduced 9.21%	9,735 $4.53 Million
Q2 2024 Jul 22, 2024	BUY	$392.81 - $485.53 $42,030 - $51,951	107 Added 1.01%	10,722 $5.03 Million
Q1 2024 May 13, 2024	BUY	$407.69 - $446.08 $8,561 - $9,367	21 Added 0.2%	10,615 $4.44 Million
Q4 2023 Feb 02, 2024	BUY	$343.0 - $410.68 $2,744 - $3,285	8 Added 0.08%	10,594 $4.31 Million
Q3 2023 Nov 08, 2023	BUY	$338.18 - $362.46 $67,636 - $72,492	200 Added 1.93%	10,586 $3.68 Million
Q2 2023 Aug 03, 2023	BUY	$314.42 - $351.91 $491,124 - $549,683	1,562 Added 17.7%	10,386 $3.65 Million
Q1 2023 Aug 22, 2023	SELL	$283.23 - $323.1 $235,080 - $268,173	-830 Reduced 7.99%	9,556 $3.01 Million
Q1 2023 Jun 14, 2023	SELL	$283.23 - $323.1 $207,324 - $236,509	-732 Reduced 7.66%	8,824 $2.78 Million
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $192,313 - $219,384	679 Added 7.65%	9,556 $3.01 Million
Q4 2022 Aug 30, 2023	SELL	$285.76 - $321.48 $446,357 - $502,151	-1,562 Reduced 15.04%	8,824 $2.55 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $206,604 - $232,430	-723 Reduced 7.53%	8,877 $2.56 Million
Q3 2022 Feb 13, 2023	BUY	$273.83 - $305.53 $1.01 Million - $1.13 Million	3,692 Added 62.49%	9,600 $2.78 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $360,634 - $402,383	1,317 Added 28.69%	5,908 $1.71 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $337,167 - $419,809	-1,435 Reduced 23.81%	4,591 $1.29 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $1.33 Million - $1.57 Million	6,026 New	6,026 $1.57 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.

Account

Atria Wealth Solutions, Inc. Vertex Pharmaceuticals Inc Transaction History